Qpex Biopharma, Inc. Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Qpex Biopharma, Inc. is a San Diego‑based biotechnology company that concentrates on infectious diseases with a focus on drug resistance. It develops and advances treatments designed to overcome multi-drug resistance, aiming to improve patient care in a sustainable way and to deliver the right therapies to the right patients in the right settings. Over the past decade, the team has helped bring four antibiotic products to regulatory approvals and has a history of collaborations with public-private partners, including BARDA.

In 2023, Qpex Biopharma became part of Shionogi, Inc., operating as a Shionogi Group Company. The company has engaged in international partnerships to advance anti-infective programs, including a 2019 licensing arrangement with Brii Bio to develop BRII-693 and QPX7728-based products in Greater China.

Sign up for free to view info

Company overview Employee directory